Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119811442 | 11981144 | 2 | F | 20160410 | 20160129 | 20160804 | PER | US-ASTRAZENECA-2016SE06671 | ASTRAZENECA | 0.00 | F | Y | 98.00000 | KG | 20160805 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119811442 | 11981144 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 2.0MG UNKNOWN | 22200 | 2 | MG | ||||||||
| 119811442 | 11981144 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 2.0MG UNKNOWN | 22200 | 2 | MG | ||||||||
| 119811442 | 11981144 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | Y | U | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 119811442 | 11981144 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | TABLET | ||||||||||
| 119811442 | 11981144 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119811442 | 11981144 | 6 | C | THYROID MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 119811442 | 11981144 | 7 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 119811442 | 11981144 | 8 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 119811442 | 11981144 | 9 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 119811442 | 11981144 | 10 | C | VICTOZA | LIRAGLUTIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119811442 | 11981144 | 1 | Type 2 diabetes mellitus |
| 119811442 | 11981144 | 2 | Type 2 diabetes mellitus |
| 119811442 | 11981144 | 3 | Type 2 diabetes mellitus |
| 119811442 | 11981144 | 5 | Type 2 diabetes mellitus |
| 119811442 | 11981144 | 6 | Thyroid disorder |
| 119811442 | 11981144 | 7 | Blood cholesterol abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119811442 | 11981144 | Abdominal discomfort | |
| 119811442 | 11981144 | Hypoaesthesia | |
| 119811442 | 11981144 | Injection site bruising | |
| 119811442 | 11981144 | Injection site extravasation | |
| 119811442 | 11981144 | Injection site nodule | |
| 119811442 | 11981144 | Nausea | |
| 119811442 | 11981144 | Product quality issue | |
| 119811442 | 11981144 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119811442 | 11981144 | 1 | 201512 | 0 | ||
| 119811442 | 11981144 | 2 | 201601 | 0 | ||
| 119811442 | 11981144 | 3 | 2011 | 0 |